We are live on ! Find out more
BL

Balentine LLC Portfolio holdings

AUM $2.48B
1-Year Est. Return 17.44%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+17.44%
3 Year Est. Return
+46.33%
5 Year Est. Return
+51.14%
10 Year Est. Return
+189.48%
AUM
$486M
AUM Growth
-$60.4M
Cap. Flow
-$90M
Cap. Flow %
-18.53%
Top 10 Hldgs %
89.49%
Holding
504
New
50
Increased
102
Reduced
110
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 3.14%
2 Consumer Staples 2.38%
3 Financials 2.33%
4 Energy 2.19%
5 Industrials 0.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HMC icon
76
Honda
HMC
$36.5B
$187K 0.04%
5,864
-122
-2% -$3.96K
VNQ icon
77
Vanguard Real Estate ETF
VNQ
$39.9B
$185K 0.04%
+2,323
New +$184K
AMGN icon
78
Amgen
AMGN
$203B
$183K 0.04%
1,128
+330
+41% +$51.9K
SLB icon
79
SLB Ltd
SLB
$77.8B
$180K 0.04%
2,576
+30
+1% +$2.25K
WES
80
DELISTED
Western Gas Partners Lp
WES
$179K 0.04%
3,770
EBAY icon
81
eBay
EBAY
$48.6B
$177K 0.04%
6,440
-1,800
-22% -$49.7K
TSM icon
82
TSMC
TSM
$2.09T
$175K 0.04%
7,705
-536
-7% -$12.1K
EFA icon
83
iShares MSCI EAFE ETF
EFA
$76.4B
$172K 0.04%
+2,925
New +$176K
IBM icon
84
IBM
IBM
$202B
$165K 0.03%
1,254
-1,158
-48% -$156K
META icon
85
Meta Platforms (Facebook)
META
$1.51T
$162K 0.03%
1,550
+121
+8% +$12.4K
STI
86
DELISTED
SunTrust Banks, Inc.
STI
$161K 0.03%
3,766
+172
+5% +$7.24K
BMY icon
87
Bristol-Myers Squibb
BMY
$127B
$159K 0.03%
2,311
+886
+62% +$58.5K
GSK icon
88
GSK
GSK
$103B
$146K 0.03%
2,888
+602
+26% +$30.7K
UNH icon
89
UnitedHealth
UNH
$382B
$145K 0.03%
1,229
SHLX
90
DELISTED
Shell Midstream Partners, L.P.
SHLX
$138K 0.03%
3,316
+1,220
+58% +$42.8K
PSXP
91
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$132K 0.03%
2,146
+362
+20% +$21K
MTB icon
92
M&T Bank
MTB
$36.2B
$125K 0.03%
1,030
-275
-21% -$33.5K
VZ icon
93
Verizon
VZ
$194B
$121K 0.02%
2,622
-43
-2% -$1.95K
GE icon
94
GE Aerospace
GE
$367B
$120K 0.02%
806
+496
+160% +$70.4K
BLK icon
95
Blackrock
BLK
$164B
$119K 0.02%
349
BEN icon
96
Franklin Resources
BEN
$16.9B
$118K 0.02%
3,210
-990
-24% -$38.7K
LNC icon
97
Lincoln National
LNC
$7.91B
$118K 0.02%
2,345
+345
+17% +$18.1K
PRGO icon
98
Perrigo
PRGO
$1.4B
$118K 0.02%
814
+470
+137% +$72.3K
PFE icon
99
Pfizer
PFE
$140B
$116K 0.02%
3,775
+1,285
+52% +$40.4K
OKS
100
DELISTED
Oneok Partners LP
OKS
$113K 0.02%
3,754
+1,638
+77% +$49.7K

Similar funds

Balentine LLC's Q4 2015 Portfolio in Review

As of Q4 2015, Balentine LLC held 504 positions worth $486M, down 11% from $546M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Balentine LLC withdrew a net $90M in Q4 2015, closing 88 positions and reducing 110 holdings. Its most notable exit was Gilead Sciences, an estimated $387K position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Balentine LLC opened a new position in Vanguard FTSE All-World ex-US ETF worth $4.24M.

  • Balentine LLC's largest Q4 2015 buy was Vanguard FTSE All-World ex-US ETF: 97,700 shares worth $4.24M.
  • Balentine LLC added most to iShares Russell 2000 ETF in Q4 2015, an estimated $1.12M increase.
  • Balentine LLC's biggest Q4 2015 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $42.7M.
  • Balentine LLC fully exited Gilead Sciences in Q4 2015, selling an estimated $387K.
  • Balentine LLC's ten largest holdings make up 89% of its $486M portfolio in Q4 2015.
  • Balentine LLC opened 50 new positions and closed 88 in Q4 2015.
  • Balentine LLC's portfolio value fell 11% quarter-over-quarter to $486M.

Based on Balentine LLC's 13F filing for Q4 2015, filed 16 Feb 2016.